News
Investment Summary Following a series of investment updates since my April publication on Avanos Medical, Inc. (NYSE:AVNS), there is still the potential to unlock...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
News
This article was written by Follow Robert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options, mainly covered...
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
Investment Thesis Capstone Copper Corp. (OTCPK:CSCCF) is forecasted to more than double output by 2026 as it ramps up two mining projects in Chile,...
News
Earnings season amps into full swing this week with many big names issuing Q2 results. So far, according to FactSet, 80% of S&P 500...
News
Introduction Invitae (NYSE:NVTA) is a leading provider of genetic testing services, digital health solutions, and health data services. Their genetic tests cover various clinical...
News
Value investing is about obtaining more value than the amount of money that you are putting in. There are metrics to track whether intrinsic...
News
It has been roughly four months since the regional banking crisis started with the failure of Silicon Valley Bank in March. With several months...
News
Introduction I am a big fan of stocks that fall in the growth/value hybrid category. Companies that are profitable with a wide moat, capable...
News
Get ahead of the market by subscribing to Seeking Alpha’s Stocks to Watch, a preview of key events scheduled for the coming week. The...
News
Review and Outlook Wedgewood Composite Net 2Q 8.1 YTD 18.7 1-Year 19.7 3-Year 13.3 5-Year 13.5 Standard & Poor’s 500 Index (SP500, SPX) 8.7...
News
Introduction It has been four years since I last discussed Bekaert (OTCPK:BEKSF) (OTCPK:BEKAY) and back in 2019 I argued that Bekaert was worth having...
